Severe Hepatic Adverse Event Induced by Anti‐HER2 Therapy in Breast Cancer: A Case of Successful Immunotherapy With Baricitinib

ACR Open Rheumatology 2026 Open access

Read full text
Authors: Yufei Li, Yifan Wang, Miao Shao, Jing He
DOI: 10.1002/acr2.70163
Cited by: 0
References: 5

Fields of Study & Subjects

HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers Drug-Induced Hepatotoxicity and Protection

Publication details

Journal / source
ACR Open Rheumatology
Volume
8
Issue
2
Pages
e70163–e70163
Publication date
29 January 2026
Language
EN